234 related articles for article (PubMed ID: 30513929)
1. The Healing-Promoting Properties of Selected Cyclitols-A Review.
Owczarczyk-Saczonek A; Lahuta LB; Ligor M; Placek W; Górecki RJ; Buszewski B
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513929
[TBL] [Abstract][Full Text] [Related]
2. Health-Promoting Properties of Selected Cyclitols for Metabolic Syndrome and Diabetes.
Antonowski T; Osowski A; Lahuta L; Górecki R; Rynkiewicz A; Wojtkiewicz J
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31574903
[TBL] [Abstract][Full Text] [Related]
3. Analyses of Antioxidative Properties of Selected Cyclitols and Their Mixtures with Flavanones and Glutathione.
Płonka J; Szablińska-Piernik J; Buszewski B; Baranowska I; Lahuta LB
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011390
[TBL] [Abstract][Full Text] [Related]
4. Exogenously Applied Cyclitols and Biosynthesized Silver Nanoparticles Affect the Soluble Carbohydrate Profiles of Wheat (
Lahuta LB; Szablińska-Piernik J; Stałanowska K; Horbowicz M; Górecki RJ; Railean V; Pomastowski P; Buszewski B
Plants (Basel); 2023 Apr; 12(8):. PubMed ID: 37111851
[TBL] [Abstract][Full Text] [Related]
5. Functional role of polyhydroxy compounds on protein structure and thermal stability studied by circular dichroism spectroscopy.
Ortbauer M; Popp M
Plant Physiol Biochem; 2008 Apr; 46(4):428-34. PubMed ID: 18343146
[TBL] [Abstract][Full Text] [Related]
6. Cyclitols: From Basic Understanding to Their Association with Neurodegeneration.
Derkaczew M; Martyniuk P; Osowski A; Wojtkiewicz J
Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432155
[TBL] [Abstract][Full Text] [Related]
7. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Croze ML; Soulage CO
Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
[TBL] [Abstract][Full Text] [Related]
8. New approach for fast identification of cyclitols by MALDI-TOF mass spectrometry.
Al-Suod H; Pomastowski P; Ligor M; Railean-Plugaru V; Buszewski B
Phytochem Anal; 2018 Sep; 29(5):528-537. PubMed ID: 29732635
[TBL] [Abstract][Full Text] [Related]
9. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
Minozzi M; Nordio M; Pajalich R
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):537-40. PubMed ID: 23467955
[TBL] [Abstract][Full Text] [Related]
10. Enantiospecific synthesis and insect feeding activity of sulfur-containing cyclitols.
Bellomo A; Camarano S; Rossini C; Gonzalez D
Carbohydr Res; 2009 Jan; 344(1):44-51. PubMed ID: 18950751
[TBL] [Abstract][Full Text] [Related]
11. New Methodology for the Identification of Metabolites of Saccharides and Cyclitols by Off-Line EC-MALDI-TOF-MS.
Sagandykova G; Walczak-Skierska J; Monedeiro F; Pomastowski P; Buszewski B
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722273
[TBL] [Abstract][Full Text] [Related]
12. Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.
Campbell WW; Ostlund RE; Joseph LJ; Farrell PA; Evans WJ
Horm Metab Res; 2001 Jan; 33(1):44-51. PubMed ID: 11280715
[TBL] [Abstract][Full Text] [Related]
13. Stereocontrolled total synthesis of tetrodotoxin from myo-inositol and D-glucose by three routes: aspects for constructing complex multi-functionalized cyclitols with branched-chain structures.
Sato K; Akai S; Yoshimura J
Nat Prod Commun; 2015 May; 10(5):691-702. PubMed ID: 26058138
[TBL] [Abstract][Full Text] [Related]
14. D-chiro-inositol affects accumulation of raffinose family oligosaccharides in developing embryos of Pisum sativum.
Lahuta LB; Dzik T
J Plant Physiol; 2011 Mar; 168(4):352-8. PubMed ID: 20947202
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB inhibitory activity of cyclitols isolated from Hancornia speciosa.
Endringer DC; Pezzuto JM; Braga FC
Phytomedicine; 2009 Nov; 16(11):1064-9. PubMed ID: 19423310
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of the aminocyclitol units of (-)-hygromycin A and methoxyhygromycin from myo-inositol.
Gurale BP; Shashidhar MS; Gonnade RG
J Org Chem; 2012 Jul; 77(13):5801-7. PubMed ID: 22663090
[TBL] [Abstract][Full Text] [Related]
17. The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.
Gateva A; Unfer V; Kamenov Z
Gynecol Endocrinol; 2018 Jul; 34(7):545-550. PubMed ID: 29309199
[TBL] [Abstract][Full Text] [Related]
18. From Myo-inositol to D-chiro-inositol molecular pathways.
Kiani AK; Paolacci S; Calogero AE; Cannarella R; Di Renzo GC; Gerli S; Della Morte C; Busetto GM; De Berardinis E; Del Giudice F; Stuppia L; Facchinetti F; Dinicola S; Bertelli M
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2390-2402. PubMed ID: 33755975
[TBL] [Abstract][Full Text] [Related]
19. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
Pizzo A; Laganà AS; Barbaro L
Gynecol Endocrinol; 2014 Mar; 30(3):205-8. PubMed ID: 24351072
[TBL] [Abstract][Full Text] [Related]
20. Cancer Prevention by Natural Products Introduced into the Diet-Selected Cyclitols.
Wiśniewski K; Jozwik M; Wojtkiewicz J
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
